Published in Thorac Cardiovasc Surg on December 01, 2001
Pulmonary and caval blood flow patterns in patients with intracardiac and extracardiac Fontan: a magnetic resonance study. Clin Res Cardiol (2006) 0.89
Comparison of Fontan survivors with and without pacemakers: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. Congenit Heart Dis (2012) 0.88
Arrhythmias in Complex Congenital Heart Disease. Card Electrophysiol Clin (2014) 0.78
The Fontan pathway: What's down the road? Ann Pediatr Cardiol (2008) 0.76
Preserved regional atrial contractile function following extra-atrial rather than intra-atrial type Fontan operation: a tissue Doppler imaging study. Clin Res Cardiol (2007) 0.75
[Antibradycardia therapy : Indication and implementation]. Herzschrittmacherther Elektrophysiol (2016) 0.75
Arrhythmias After Fontan Operation with Intra-atrial Lateral Tunnel Versus Extra-cardiac Conduit: A Systematic Review and Meta-analysis. Pediatr Cardiol (2017) 0.75
Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res (1999) 2.38
Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder. Cardiol Young (1999) 2.26
Anomalous origin of the left coronary artery from the pulmonary artery in adults. J Card Surg (1995) 2.16
Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation (1997) 2.16
Using aortic allograft material to treat mycotic aneurysms of the thoracic aorta. Ann Thorac Surg (1996) 2.14
Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg (1999) 1.97
Cerebral oxygen monitoring during neonatal cardiopulmonary bypass and deep hypothermic circulatory arrest. Thorac Cardiovasc Surg (2002) 1.93
Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg (1999) 1.84
Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess--11 year results. Eur Heart J (2000) 1.82
Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg (1998) 1.82
Myocardial catecholamine content after heart transplantation. Circulation (1990) 1.69
Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation. Eur Heart J (2003) 1.65
Repair of coarctation of the aorta in adults: the fate of systolic hypertension. Ann Thorac Surg (1996) 1.64
The importance of secondary mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation. Eur Heart J (2002) 1.61
Reduction of intimal and medial thickening in sheathed vein grafts. Ann Thorac Surg (1999) 1.60
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol (2001) 1.55
Heterotaxia syndrome and autosomal dominant inheritance. Am J Med Genet (1995) 1.55
Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J (2001) 1.53
Correction of complete atrioventricular septal defects with the double-patch technique and cleft closure. Ann Thorac Surg (1996) 1.51
[Severe complications caused by inattention to endocarditis prevention during dental procedures in adults with congenital heart abnormalities]. Dtsch Med Wochenschr (2000) 1.47
Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. Int J Cardiol (2000) 1.47
Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. Circulation (2000) 1.47
Development of pulmonary arteries after central aortopulmonary shunt in newborns. Ann Thorac Surg (2001) 1.45
Plasma endothelin-1 in patients with left-to-right shunt. Am Heart J (1995) 1.45
Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs. J Heart Lung Transplant (2001) 1.45
Myocardial preservation using HTK solution for heart transplantation. A multicenter study. Eur J Cardiothorac Surg (1993) 1.43
Left atrial appendage closure devices. Their role in 2013. Minerva Cardioangiol (2013) 1.39
[Non-invasive monitoring of rejection after cardiac transplantation. The method and retrospective analysis of data on 734 patients]. Dtsch Med Wochenschr (2001) 1.39
Anomalous origin of the left coronary artery from the pulmonary artery. Early results with direct aortic reimplantation. J Thorac Cardiovasc Surg (1994) 1.33
Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv (2005) 1.29
Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet (2003) 1.28
Primary cardiac tumours: when is surgery necessary? Eur J Cardiothorac Surg (2001) 1.27
Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol (2001) 1.24
Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation (2000) 1.22
Left and right ventricular adaptation to right ventricular overload before and after surgical repair of tetralogy of Fallot. Am J Cardiol (1982) 1.21
Morphology of perforated atrial septal aneurysm suitable for closure by transcatheter device placement. Heart (2000) 1.15
Transcatheter closure of atrial septal defects without fluoroscopy: feasibility of a new method. Circulation (2000) 1.14
Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol (1987) 1.14
Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder. Cardiol Young (2000) 1.14
Benefits of surgical repair of coarctation of the aorta in patients older than 50 years. Ann Thorac Surg (2001) 1.13
Further experience with the two-stage anatomic correction of simple transposition of the great arteries. Thorac Cardiovasc Surg (1981) 1.12
Radiofrequency-assisted "reconstruction" of the right ventricular outflow tract in muscular pulmonary atresia with ventricular septal defect. Br Heart J (1993) 1.12
Regulation of human heart contractility by essential myosin light chain isoforms. J Clin Invest (1996) 1.12
European Contegra multicentre study: 7-year results after 165 valved bovine jugular vein graft implantations. Thorac Cardiovasc Surg (2009) 1.09
Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Clin Microbiol Infect (2009) 1.09
Comparison of transthoracic three dimensional echocardiography with magnetic resonance imaging in the assessment of right ventricular volume and mass. Heart (1997) 1.09
Accelerated degeneration of allografts in the first two years of life. Ann Thorac Surg (1995) 1.09
[Interventional treatment of congenital heart defects in infants with a body weight up to 2,500 grams]. Z Kardiol (2000) 1.08
A modified repair technique for tricuspid incompetence in Ebstein's anomaly. J Thorac Cardiovasc Surg (1998) 1.08
Right pulmonary artery-to-left atrium communication: a rare cause of systemic cyanosis. Tex Heart Inst J (2001) 1.06
Extended donor criteria for heart transplantation. J Heart Transplant (1989) 1.06
Maldevelopment of conotruncal and aorto-pulmonary septum with absent left central pulmonary artery: anatomical and clinical implications. Br Heart J (1994) 1.06
Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Pediatr Transplant (2008) 1.06
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban. Anesthesiology (2001) 1.03
Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr (1998) 1.02
Arterial switch procedure for D-transposition of the great arteries: quantitative midterm evaluation of hemodynamic changes with cine MR imaging and phase-shift velocity mapping-initial experience. Radiology (2000) 1.01
Complications of permanent transvenous cardiac pacing. J Thorac Cardiovasc Surg (1975) 1.01
Optimal conduit size for extracardiac Fontan operation. Eur J Cardiothorac Surg (2000) 1.00
Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol (2001) 1.00
The biocompound method in coronary artery bypass operations: surgical technique and 3-year patency. Ann Thorac Surg (2000) 1.00
Peritoneal dialysis after infant open heart surgery: observations in 27 patients. Ann Thorac Surg (1999) 1.00
Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med (Berl) (2000) 0.99
Dimensions of the great arteries, semilunar valve roots, and right ventricular outflow tract during growth: normative angiocardiographic data. Pediatr Cardiol (1984) 0.99
Prolonged open sternotomy after pediatric open heart operation: experience with 113 patients. Ann Thorac Surg (1995) 0.98
Neurodevelopment at 1 year of age in infants with congenital heart disease. Heart (2003) 0.98
Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience. Eur J Cardiothorac Surg (2002) 0.98
First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension. Eur J Clin Invest (2006) 0.98